A client is to receive filgrastim (Neupogen) as a ...

[ec501234]

A client is to receive filgrastim (Neupogen) as a granulocyte-stimulating factor. The nurse recognizes that this medication should not be given when the client has:
 
  a. severe myelosuppression.
  b. a history of hypertension.
  c. received cytotoxic agents less than 24 hours before.
  d. a neutrophil count lower than 500.

Question 2

A client is taking G-CSF, or filgrastim (Neupogen). Which nursing interventions are indicated for the most common side effect of this medication?
 
  a. Stool softeners and a high-fiber diet for constipation
  b. High fluid intake and vitamin C for alkaline urine
  c. Acetaminophen (Tylenol) and assessment for fever
  d. Nonnarcotic analgesia and comfort measures for pain

[pangili4]

Answer to Question 1

ANS: C
The medication should not be given within 24 hours of receiving chemotherapy agents.

Answer to Question 2

ANS: D
Bone pain is the most common side effect of the granulocyte colony-stimulating factors.

[ec501234]

YES! Correct, THANKS for helping me on my review

[amynguyen1221]

Thanks for the timely response, appreciate it